A Study of the Effectiveness of Cabozantinib in Combination With Nivolumab as First-line Treatment of Advanced Renal Cell Carcinoma (aRCC) in Adults
Clinical trial NCT05361434 · COMPLETED
Trial details
- NCT number
- NCT05361434
- Sponsor
- Ipsen
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-26
- Primary completion
- 2025-10-20
- Enrollment
- 311
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.